window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-W287TTH7MD');

Partner News

PI Anguraj Sadanandam, The ICR publishes two COLOSSUS-related studies

2021-03-16T15:36:58+00:00March 16th, 2021|

PI Dr Anguraj  Sadanandam of The Institute for Cancer Research in London announced that he, his lab team and colleagues published two important colorectal cancer studies in the last two weeks which are related to COLOSSUS research. Both papers are available open-access: Differential and longitudinal immune gene patterns associated with reprogrammed microenvironment and viral mimicry [...]

Dr Anguraj Sadanandam appointed Director of Centre for Global Oncology, ICR

2021-03-10T14:36:45+00:00March 10th, 2021|

Dr Anguraj Sadanandam, ICR As of today, March 10, 2021, the Centre for Global Oncology is a new entity at the Institute of Cancer Research (ICR) in London! The ICR unanimously approved COLOSSUS PI Dr Anguraj Sadanandam's initiation of this new Centre and appointed him as its Director. Congratulations Anguraj! Dr Sadanandam applies the [...]

COLOSSUS-acknowledged study by UNITO team in Cancer Discovery

2021-01-26T10:08:24+00:00January 26th, 2021|

The team of researchers at the Universita degli Studi di of Torino (UNITO) consisting of V. Amodio, R. Yaeger, P. Arcella, C. Cancelliere, S. Lamba, A. Lorenzato, S. Arena, M. Montone, B. Mussolin, Y. Bian, A. Whaley, M. Pinnelli, Y.R. Murciano-Goroff, E. Vakiani, N. Valeri, W.L. Liao, A. Bhalkikar, S. Thyparambil, H.Y. Zhao, E. de [...]

INSERM researchers co-publish COLOSSUS study in Genome Medicine

2021-01-14T12:53:40+00:00January 14th, 2021|

Congratulations to the following team of researchers, many of whom are our partners at INSERM: Florent Petitprez, Sacha Levy, Cheng-Ming Sun, Maxime Meylan, Christophe Linhard, Etienne Becht, Nabila Elarouci, David Tavel, Lubka T. Roumenina, Mira Ayadi, Catherine Sautès-Fridman, Wolf H. Fridman and Aurélien de Reyniès on their recent publication in Genome Medicine. Their open-access study: [...]

VIB to host 2021 online conference ‘Tumor heterogeneity, plasticity and therapy’

2020-12-22T11:05:38+00:00December 22nd, 2020|

Our partners at VIB (https://vib.be/) are hosting the first edition of "Tumor Heterogeneity, Plasticity and therapy" conference albeit an online one. COLOSSUS PI Prof Diether Lambrechts is on the organizing committee. The conference will be held on May 5-6, 2021. Here, world leaders from academia and industry will discuss the latest developments in basic research, [...]

Dr Anguraj Sadanandam, ICR trains tomorrow’s leaders in cancer research and data science

2020-10-07T11:06:22+00:00October 5th, 2020|

Are you/do you know a student who wants to work on real-time projects in bioinformatics?  Curious to simplify the complex or predict the unpredictables of biology? Please consider this valuable training! Pay It Forward Machine Learning Training Association is the brainchild of COLOSSUS PI Dr Anguraj Sadanandam from the Institute of Cancer Research (ICR), in [...]

PI Anguraj Sadanandam of The ICR publishes 3 important COLOSSUS-related studies

2020-10-05T10:42:31+00:00October 5th, 2020|

Our PI Dr Anguraj  Sadanandam of The Institute for Cancer Research in London shares three unique studies he and his team published in the last few days which are related to COLOSSUS research. The first and third papers below are followup studies on their interest in colorectal cancer and span work for almost 10 years! [...]

HalioDx Immunoscore® identifies candidates for Phase II Colorectal Cancer Trial

2020-09-17T09:47:14+00:00September 16th, 2020|

We report more exciting news about the Immunoscore® diagnostic tool developed by our partners at HalioDx! The immuno-oncology diagnostic company, HalioDx announced last week that it has entered into a Collaboration Agreement with the FFCD, the French Cooperative Group dedicated exclusively to digestive oncology, on the Phase II multi-center POCHI trial (FFCD1703 - NCT04262687) in which [...]

HalioDx Immunoscore® embedded in 2020 ESMO Clinical Practice Guidelines

2020-09-02T10:44:29+00:00September 1st, 2020|

Our partners at HalioDx SAS, an immuno-oncology diagnostic company headquartered in Marseille, France, recently announced that their diagnostic test Immunoscore® has been included in the 2020 European Society of Medical Oncology (ESMO) Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up for Localised Colon Cancer. Immunoscore® was considered for its ability to refine the prognosis for [...]

Partner News: Ireland establishes first National Preclinical Imaging Centre

2020-06-17T11:40:25+00:00June 17th, 2020|

Prof Annette Byrne, RCSI, COLOSSUS Coordinator, NPIC Director In Ireland, a new National Preclinical Imaging Centre (NPIC) which will provide enhanced research data to inform new clinical trials that aim to improve patient outcomes, has been awarded funding of €3.4 million under Science Foundation Ireland's (SFI) Research Infrastructure Programme. COLOSSUS Coordinator, Prof Annette [...]

Go to Top